| Literature DB >> 24053587 |
Valerie Bertaud-Gounot1, Viviane Kovess-Masfety, Catherine Perrus, Gilda Trohel, Frederique Richard.
Abstract
BACKGROUND: Severe mental disorders have a chronic course associated with a high risk for co-morbid somatic illnesses and premature mortality and oral health is critical for overall systemic health. But general health care needs in this population are often neglected. Some studies have aimed at determining the oral health status of psychiatric in-patients but to date, no emphasis has been placed on oral health of psychiatric patients in France. The goal of this study was to assess the oral health and treatment needs of institutionalized patients in a large psychiatric hospital, where a dental service was available and free, to compare it with the average population, with psychiatric in-patients in other countries and to provide recommendations for psychiatrists and care-giving staff.Entities:
Mesh:
Year: 2013 PMID: 24053587 PMCID: PMC3856526 DOI: 10.1186/1471-244X-13-227
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Age and gender distribution of the sample
| 18 -24 | 9 | 9.5 | 10 | 15.2 | 19 | 11.8 |
| 25-34 | 19 | 20.0 | 6 | 9.1 | 25 | 15.5 |
| 35-44 | 21 | 22.1 | 15 | 22.7 | 36 | 22.4 |
| 45-54 | 23 | 24.2 | 11 | 16.7 | 34 | 21.1 |
| 55-64 | 11 | 11.6 | 11 | 16.7 | 22 | 13.7 |
| ≥65 | 12 | 12.6 | 13 | 19.7 | 25 | 15.6 |
| 95 | 100.0 | 66 | 100.0 | 161 | 100.0 | |
Medical, salivary, behavioural characteristics of the sample
| | | ||||
|---|---|---|---|---|---|
| F00-F09 | Organic including symptomatic, mental disorders | 13 | 8,1 | ||
| F10-F19 | Mental and behavioral disorders due to psychoactive substance use | 20 | 12.4 | ||
| F20-F29 | Schizophrenia, schizotypal and delusionaldisorders | 59 | 36.6 | ||
| F30-F39 | Mood [affective] disorders | 34 | 21.1 | ||
| F40-F49 | Neurotic, stress-related and somatoform disorders | 6 | 3.7 | ||
| F60-F69 | Disorders of adult personality and behavior | 4 | 2.5 | ||
| F70-F79 | Mental retardation | 12 | 7.5 | ||
| F80-F89 | Disorders of psychological development | 6 | 3.7 | ||
| F90-F98 | Behavioural and emotional disorders with onset in childhood and adolescence | 2 | 1.2 | ||
| Unknown | | 5 | 3.1 | ||
| | | ||||
| | | | | ||
| <1 year | 90 | 55.9 | <1 | 49 | 34.3 |
| 1-4 y | 28 | 17.4 | 1-1.9 | 73 | 51.0 |
| 5-19 y | 30 | 18.6 | ≥2 | 18 | 12.6 |
| ≥20 y | 13 | 8.1 | Unknown | 3 | 2.1 |
| | | | | ||
| Classic antipsychotic | 78 | 48.4 | <1 | 111 | 77.6 |
| Atypical antipsychotic | 77 | 47.8 | 1-1.9 | 22 | 15.4 |
| Anxiolytics | 70 | 43.5 | ≥2 | 7 | 4.9 |
| Hypnotics an sedatives | 61 | 37.9 | Unknown | 3 | 2.1 |
| Antidepressants | 51 | 31.7 | | | |
| | | Excellent (0) | 1 | 0.7 | |
| Self sufficient | 85 | 52.8 | Good (0.1-1.2) | 64 | 44.8 |
| Partially or totally disabled | 76 | 47.2 | Fair (1.3-3.0) | 59 | 41.3 |
| | | Poor (3.1-6.0) | 16 | 11.2 | |
| ≤0.3 | 89 | 60.5 | Unknown | 3 | 2.1 |
| >0.3 | 58 | 39.5 | | | |
| | | | | | |
| Never | 18 | 12.6 | | | |
| < once a day | 26 | 18.2 | | | |
| Once a day | 93 | 65.0 | | | |
| Unknown | 6 | 4.2 | |||
Tooth decay index (DMFT scores) by age, gender,psychiatric disorder and length of hospitalization
| 0.63 | ||||
| <24 | 3.4 (4.2) | 0.1 (0.5) | 2.6 (2.4) | 6.1 (4.7) |
| 25-34 | 3.1 (2.8) | 1.1 (2.4) | 7.5 (5.0) | 11.7 (7.2) |
| 35-44 | 5.0 (6.4) | 3.0 (5.0) | 6.4 (5.1) | 14.5 (7.8) |
| 45-54 | 3.1 (2.8) | 10.3 (10.3) | 4.4 (5.1) | 17.8 (8.2) |
| 55-64 | 4.4 (4.9) | 10.1 (8.1) | 4.5 (4.5) | 19.0 (7.1) |
| 65-74 | 4.2 (3.6) | 15.4 (8.6) | 3.0 (4.3) | 22.6 (8.2) |
| 75-90 | 1.7 (2.4) | 21.6 (9.1) | 0.8 (2.5) | 24.1 (6.1) |
| 0.20 | 0.68 | 0.55 | 0.512 | |
| Female | 3.1 (3.7) | 7.8 (9.8) | 4.5 (4.6) | 15.4 (9.1) |
| Male | 4.1 (4.8) | 7.0 (9.2) | 4.9 (5.0) | 16.1 (8.6) |
| 0.38 | 0.16 | |||
| Organic mental disorders | 2.6 (3.2) | 17.5 (10.6) | 0.7 (1.9) | 20.8 (9.3) |
| Disorders due to psychoactive substance | 5.1 (3.1) | 6.6 (8.5) | 5.0 (4.7) | 16.7 (7.4) |
| Schizophrenia | 3.7 (4.6) | 5.5 (9.0) | 5.5 (5.1) | 14.6 (8.7) |
| Mood disorders | 2.5 (2.6) | 6.8 (8.3) | 6.2 (4.8) | 15.5 (8.1) |
| Somatoform disorders | 3.5 (4.3) | 1.3 (2.4) | 1.8 (2.6) | 6.7 (8.3) |
| Disorders of adult personality | 4.0 (3.6) | 1.5 (1.9) | 8.5 (4.0) | 14.0 (6.8) |
| Mental retardation | 4.2 (5.4) | 11.2 (9.8) | 4.0 (5.4) | 19.3 (9.0) |
| Developmental disorders | 5.7 (9.6) | 9.3 (10.1) | 0.7 (1.6) | 15.7 (12.8) |
| Behavioral and emotional disorders | 8.5 (10.6) | 0.0 (0.0) | 3.5 (0.7) | 12.0 (9.9) |
| 0.41 | ||||
| <1 | 3.7 (4.0) | 6.4 (9.1) | 5.0 (4.9) | 15.1 (8.6) |
| 1-4 | 3.4 (3.2) | 4.6 (7.1) | 6.1 (5.5) | 14.1 (8.2) |
| 5-19 | 4.9 (6.4) | 7.7 (9.1) | 4.53 (4.61) | 17.1 (8.6) |
| ≥20 | 2.2 (2.6) | 19.6 (9.2) | 0.8 (1.2) | 22.6 (8.2) |
| Total | 3.7 (4.4) | 7.3 (9.4) | 4.7 (4.9) | 15.8 (8.8) |
NS = Not Significant p > 0.05.
*ANOVA, p < 0.05.
Bivariate analysis of the number (%) of psychiatric patients for the DMFT-16 (less or more than 16)
| | | |||
|---|---|---|---|---|
| | | | | |
| ≤45 | 80 | 55 (68.8) | 25 (30.9) | 23.1 |
| >45 | 81 | 25 (31.3) | 56 (69.1) | *p < 0.0001 |
| | | | | |
| Men | 95 | 48 (60.0) | 47(58.0) | 0.06 |
| Women | 66 | 32 (40.0) | 34 (42.0) | p = 0.7989 |
| | | | ||
| Disorders due to psychoactive substance | 20 | 9 (15.0) | 11 (20.8) | 1.1 |
| Schizophrenia | 59 | 34 (56.7) | 25 (47.2) | p = 0.5645 |
| Mood disorders | 34 | 17 (28.3) | 17 (32.1) | |
| ≤5 | 118 | 65 (81.3) | 53 (65.4) | 5.1 |
| >5 | 43 | 15 (18.8) | 28 (34.6) | *p = 0.0233 |
| | | | | |
| Self sufficient | 85 | 52 (65.0) | 33 (47.7) | 9.5 |
| Partially or totally disabled | 76 | 28 (35.0) | 48 (59.3) | *p = 0.0021 |
| | | | | |
| ≤0.3 | 89 | 50 (64.9) | 39 (55.7) | 1.3 |
| >0.3 | 58 | 27 (35.1) | 31 (44.3) | p = 0.2533 |
| | | | | |
| ≤1 | 81 | 50 (66.7) | 31 (45.6) | 6.5 |
| >1 | 62 | 25 (33.3) | 37 (54.4) | *p = 0.0111 |
*Significant difference between two groups by χ2 test.
Comparison with French population
| | | | | |
| 35–44 | 14.5 | 5.0 | 3.0 | 6.4 |
| 65-74 | 22.6 | 4.2 | 15.4 | 3.0 |
| | | | | |
| 14.6 | 1.2 | 3.0 | 10.4 | |
| High occupational group (OG) | 13.7 | 0.9 | 2.0 | 10.8 |
| Low OG | 14.8 | 1.3 | 3.6 | 9.9 |
| 23.3 | 1.1 | 16.9 | 5.2 | |
| High OG | 19.4 | 0.9 | 10.2 | 8.4 |
| Low OG | 24.5 | 1.2 | 19.4 | 4.0 |